194 related articles for article (PubMed ID: 15451007)
1. Impact of serum on clearance predictions obtained from suspensions and primary cultures of rat hepatocytes.
Blanchard N; Richert L; Notter B; Delobel F; David P; Coassolo P; Lavé T
Eur J Pharm Sci; 2004 Oct; 23(2):189-99. PubMed ID: 15451007
[TBL] [Abstract][Full Text] [Related]
2. A convenient in vitro screening method for predicting in vivo drug metabolic clearance using isolated hepatocytes suspended in serum.
Shibata Y; Takahashi H; Ishii Y
Drug Metab Dispos; 2000 Dec; 28(12):1518-23. PubMed ID: 11095592
[TBL] [Abstract][Full Text] [Related]
3. Prediction of hepatic clearance using cryopreserved human hepatocytes: a comparison of serum and serum-free incubations.
Blanchard N; Hewitt NJ; Silber P; Jones H; Coassolo P; Lavé T
J Pharm Pharmacol; 2006 May; 58(5):633-41. PubMed ID: 16640832
[TBL] [Abstract][Full Text] [Related]
4. Prediction of in vitro intrinsic clearance from hepatocytes: comparison of suspensions and monolayer cultures.
Griffin SJ; Houston JB
Drug Metab Dispos; 2005 Jan; 33(1):115-20. PubMed ID: 15608354
[TBL] [Abstract][Full Text] [Related]
5. Substrate depletion approach for determining in vitro metabolic clearance: time dependencies in hepatocyte and microsomal incubations.
Jones HM; Houston JB
Drug Metab Dispos; 2004 Sep; 32(9):973-82. PubMed ID: 15319339
[TBL] [Abstract][Full Text] [Related]
6. Prediction of in vivo rat biliary drug clearance from an in vitro hepatocyte efflux model.
Lundquist P; Lööf J; Fagerholm U; Sjögren I; Johansson J; Briem S; Hoogstraate J; Afzelius L; Andersson TB
Drug Metab Dispos; 2014 Mar; 42(3):459-68. PubMed ID: 24396143
[TBL] [Abstract][Full Text] [Related]
7. Xenobiotic intrinsic clearance in freshly isolated hepatocytes from rainbow trout (Oncorhynchus mykiss): determination of trout hepatocellularity, optimization of cell concentrations and comparison of serum and serum-free incubations.
Han X; Mingoia RT; Nabb DL; Yang CH; Snajdr SI; Hoke RA
Aquat Toxicol; 2008 Aug; 89(1):11-7. PubMed ID: 18599132
[TBL] [Abstract][Full Text] [Related]
8. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes.
Riley RJ; McGinnity DF; Austin RP
Drug Metab Dispos; 2005 Sep; 33(9):1304-11. PubMed ID: 15932954
[TBL] [Abstract][Full Text] [Related]
9. The pivotal role of hepatocytes in drug discovery.
Soars MG; McGinnity DF; Grime K; Riley RJ
Chem Biol Interact; 2007 May; 168(1):2-15. PubMed ID: 17208208
[TBL] [Abstract][Full Text] [Related]
10. Effect of plasma protein binding on in vitro-in vivo correlation of biliary excretion of drugs evaluated by sandwich-cultured rat hepatocytes.
Fukuda H; Ohashi R; Tsuda-Tsukimoto M; Tamai I
Drug Metab Dispos; 2008 Jul; 36(7):1275-82. PubMed ID: 18388177
[TBL] [Abstract][Full Text] [Related]
11. Use of intrinsic clearance for prediction of human hepatic clearance.
Chao P; Uss AS; Cheng KC
Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):189-98. PubMed ID: 20073997
[TBL] [Abstract][Full Text] [Related]
12. Prediction of drug clearance by glucuronidation from in vitro data: use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin-activated human liver microsomes.
Kilford PJ; Stringer R; Sohal B; Houston JB; Galetin A
Drug Metab Dispos; 2009 Jan; 37(1):82-9. PubMed ID: 18832476
[TBL] [Abstract][Full Text] [Related]
13. Cryopreserved human hepatocytes in suspension are a convenient high throughput tool for the prediction of metabolic clearance.
Jouin D; Blanchard N; Alexandre E; Delobel F; David-Pierson P; Lavé T; Jaeck D; Richert L; Coassolo P
Eur J Pharm Biopharm; 2006 Jul; 63(3):347-55. PubMed ID: 16621491
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions.
Stringer RA; Strain-Damerell C; Nicklin P; Houston JB
Drug Metab Dispos; 2009 May; 37(5):1025-34. PubMed ID: 19196847
[TBL] [Abstract][Full Text] [Related]
15. Uptake and intracellular binding of lipophilic amine drugs by isolated rat hepatocytes and implications for prediction of in vivo metabolic clearance.
Hallifax D; Houston JB
Drug Metab Dispos; 2006 Nov; 34(11):1829-36. PubMed ID: 16882765
[TBL] [Abstract][Full Text] [Related]
16. In vitro LC-MS cocktail assays to simultaneously determine human cytochrome P450 activities.
Dixit V; Hariparsad N; Desai P; Unadkat JD
Biopharm Drug Dispos; 2007 Jul; 28(5):257-62. PubMed ID: 17443647
[TBL] [Abstract][Full Text] [Related]
17. Comparison of intrinsic clearances in human liver microsomes and suspended hepatocytes from the same donor livers: clearance-dependent relationship and implications for prediction of in vivo clearance.
Foster JA; Houston JB; Hallifax D
Xenobiotica; 2011 Feb; 41(2):124-36. PubMed ID: 21058916
[TBL] [Abstract][Full Text] [Related]
18. Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivo.
Soars MG; Grime K; Sproston JL; Webborn PJ; Riley RJ
Drug Metab Dispos; 2007 Jun; 35(6):859-65. PubMed ID: 17344337
[TBL] [Abstract][Full Text] [Related]
19. Comparison of fresh and cryopreserved rat hepatocyte suspensions for the prediction of in vitro intrinsic clearance.
Griffin SJ; Houston JB
Drug Metab Dispos; 2004 May; 32(5):552-8. PubMed ID: 15100178
[TBL] [Abstract][Full Text] [Related]
20. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes.
Obach RS
Drug Metab Dispos; 1999 Nov; 27(11):1350-9. PubMed ID: 10534321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
